SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 53.221
AS - Asia 27.269
EU - Europa 21.444
SA - Sud America 4.521
AF - Africa 604
OC - Oceania 74
Continente sconosciuto - Info sul continente non disponibili 24
AN - Antartide 2
Totale 107.159
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 52.253
SG - Singapore 10.335
FI - Finlandia 6.702
CN - Cina 6.570
IT - Italia 4.306
BR - Brasile 3.472
VN - Vietnam 2.738
UA - Ucraina 2.506
HK - Hong Kong 2.405
DE - Germania 2.164
TR - Turchia 1.624
GB - Regno Unito 1.471
FR - Francia 961
SE - Svezia 778
BD - Bangladesh 745
RU - Federazione Russa 726
PL - Polonia 662
JP - Giappone 630
IN - India 545
MX - Messico 412
CA - Canada 397
ID - Indonesia 351
AR - Argentina 348
NL - Olanda 225
IQ - Iraq 220
ZA - Sudafrica 197
EC - Ecuador 179
ES - Italia 170
CO - Colombia 166
PK - Pakistan 165
BE - Belgio 123
VE - Venezuela 114
AT - Austria 110
PH - Filippine 101
SA - Arabia Saudita 94
UZ - Uzbekistan 91
MY - Malesia 90
MA - Marocco 86
CL - Cile 77
LT - Lituania 71
CZ - Repubblica Ceca 70
IE - Irlanda 67
PY - Paraguay 66
EG - Egitto 65
AE - Emirati Arabi Uniti 59
AU - Australia 58
CH - Svizzera 56
TN - Tunisia 55
KE - Kenya 53
KR - Corea 51
JO - Giordania 42
PE - Perù 41
JM - Giamaica 35
TH - Thailandia 32
UY - Uruguay 32
IL - Israele 29
OM - Oman 29
AL - Albania 28
RO - Romania 28
DZ - Algeria 27
KZ - Kazakistan 27
TW - Taiwan 27
ET - Etiopia 25
IR - Iran 24
AZ - Azerbaigian 22
LK - Sri Lanka 22
NP - Nepal 22
SN - Senegal 22
BG - Bulgaria 21
LB - Libano 21
RS - Serbia 21
CR - Costa Rica 20
GE - Georgia 20
GR - Grecia 20
HU - Ungheria 19
PT - Portogallo 19
HR - Croazia 18
KG - Kirghizistan 18
PS - Palestinian Territory 18
BO - Bolivia 16
NO - Norvegia 16
NZ - Nuova Zelanda 15
BH - Bahrain 13
DO - Repubblica Dominicana 13
GT - Guatemala 13
HN - Honduras 13
KW - Kuwait 13
TT - Trinidad e Tobago 13
EU - Europa 12
PA - Panama 12
MD - Moldavia 11
NI - Nicaragua 11
AM - Armenia 10
BA - Bosnia-Erzegovina 10
CI - Costa d'Avorio 10
SY - Repubblica araba siriana 10
XK - ???statistics.table.value.countryCode.XK??? 10
BY - Bielorussia 9
CY - Cipro 9
DK - Danimarca 9
Totale 106.957
Salva come PNG Salva come JPEG
Città #
Singapore 6.392
Helsinki 6.052
Ashburn 5.700
Fairfield 5.338
Woodbridge 5.001
Houston 3.200
Jacksonville 2.711
San Jose 2.478
Chandler 2.390
Hong Kong 2.359
Seattle 2.132
Ann Arbor 2.106
Wilmington 1.878
Santa Clara 1.798
Cambridge 1.776
Beijing 1.775
Dallas 1.686
Izmir 960
Ho Chi Minh City 896
Nanjing 872
Princeton 751
New York 746
Los Angeles 658
Warsaw 622
Hanoi 614
Tokyo 587
Lauterbourg 550
San Diego 479
Boardman 463
Munich 431
Ferrara 422
Milan 411
Council Bluffs 347
São Paulo 325
Shanghai 289
Mexico City 265
Shenyang 264
Nanchang 245
Jakarta 234
Rome 234
Moscow 219
London 205
Chicago 202
Hefei 169
Tianjin 169
Changsha 156
Falls Church 155
Orem 150
Buffalo 148
Hebei 147
Jiaxing 147
Turku 139
Bremen 136
Redwood City 132
Bologna 127
San Mateo 122
Rio de Janeiro 121
Mountain View 119
Dong Ket 118
Montreal 116
The Dalles 116
Brooklyn 115
Brussels 115
Chennai 110
Addison 107
Frankfurt am Main 107
Da Nang 104
Haiphong 103
Johannesburg 103
Jinan 101
Naples 99
Nuremberg 93
Zhengzhou 93
Phoenix 91
Toronto 88
Atlanta 86
Tashkent 86
Norwalk 82
Stockholm 82
Dearborn 81
Baghdad 80
San Francisco 80
Guangzhou 79
Falkenstein 75
Columbus 74
Verona 74
Manchester 73
Boston 72
Washington 72
Denver 71
Belo Horizonte 67
Ningbo 65
Quito 65
Amsterdam 64
Kunming 63
Philadelphia 62
Curitiba 60
Mumbai 59
Brasília 56
Des Moines 56
Totale 72.763
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro compounds and their use as medicaments for the treatment of reperfusion injury. 2.940
17β-Estradiol Enhances Signalling Mediated by VEGF-A-Delta-Like Ligand 4-Notch1 Axis in Human Endothelial Cells 2.136
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 2.053
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.834
Il lungo cammino degli inibitori dell'enzima di conversione dell'angiotensina nella lotta per le malattie cardiovascolari 537
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 427
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 421
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 400
Valutazione ecocardiografica dell'insufficienza mitralica nella prospettiva della riparazione valvolare 394
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 373
Left ventricular ejection fraction and heart failure: an indissoluble marriage? 372
The Notch pathway: a novel therapeutic target for cardiovascular diseases? 368
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 358
Scompenso cardiaco con frazione di eiezione intermedia. Alla ricerca della Terra di Mezzo? 338
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy 320
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 320
Estrogen receptor β-dependent Notch1 activation protects vascular endothelium against tumor necrosis factor α (TNFα)-induced apoptosis 307
Polar plot maps by parametric strain echocardiography allow accurate evaluation of non-viable transmural scar tissue in ischaemic heart disease 300
Distinct gene expression profiles associated with Notch ligands Delta-like 4 and Jagged1 in plaque material from peripheral artery disease patients: A pilot study 300
Poor response to clopidogrel: current and future options for its management 289
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) 281
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 279
Cardiac resynchronization therapy guided by multimodality cardiac imaging 277
Demographic and clinical characteristics of patients with stable coronary artery disease: results from the CLARIFY registry in Spain 268
2014 ESC guidelines on the diagnosis and treatment of aortic diseases 266
CANCER THERAPY-INDUCED CARDIOTOXICITY: ROLE OF ULTRASOUND DEFORMATION IMAGING AS AN AID TO EARLY DIAGNOSIS 265
Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients 263
CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure 261
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions 260
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 260
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 259
Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study 256
A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics 255
The role of Notch pathway in cardiovascular diseases. 255
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 254
2013 ESH/ESC Guidelines for the management of arterial hypertension 253
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 250
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma 249
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 248
Abnormalities of Left Ventricular Function in Asymptomatic Patients with Systemic Sclerosis Using Doppler Measures of Myocardial Strain 244
2013 ESC guidelines on the management of stable coronary artery disease 243
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 243
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 242
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 241
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 240
Use of granulocyte-colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: clinical and angiographic safety profile 239
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 238
KRIT1 deficiency promotes aortic endothelial dysfunction 238
Aortic valve stenosis and mitochondrial dysfunctions: Clinical and molecular perspectives 236
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 235
Factor XIII-A dynamics in acute myocardial infarction: a novel prognostic biomarker? 235
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 234
Reperfusion Damage - A Story of Success, Failure, and Hope 234
EURObservational Research Programme: the Chronic Ischaemic Cardiovascular Disease Registry: Pilot phase (CICD-PILOT) 234
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review 232
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion 231
Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome 230
Attualità e nuove prospettive in tema di cardiogenetica 230
Uric acid and coronary artery disease: An elusive link deserving further attention 228
Left Ventricular Lead Position Guided by Parametric Strain Echocardiography Improves Response to Cardiac Resynchronization Therapy 227
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 226
Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry 225
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 225
Current views on anthracycline cardiotoxicity 225
Efficacy and safety of catheter ablation of atrioventricular nodal re-entrant tachycardia by means of flexible-tip irrigated catheters 224
Angina and left ventricular dysfunction: can we "reduce' it? 224
Heart failure with preserved ejection fraction: uncertainties and dilemmas 223
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 222
Hydroxyl radical generation, levels of tumor necrosis factor-alpha, and progression to heart failure after acute myocardial infarction 221
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 221
Anti-anginal drugs: Systematic review and clinical implications 220
2013 ESH/ESC Guidelines for the management of arterial hypertension 219
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 218
181 QUESTIONS & ANSWERS IN HEART FAILURE Heart failure 181 Questions & Answers. 217
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 217
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 216
Current role of echocardiography in cardiac resynchronization therapy 215
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 213
Can we improve myocardial protection during ischaemic injury? 212
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 207
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study 207
null 206
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 206
99mTc-sestamibi gted -Spect evaluation of post stress left ventricular ejection fraction and volumes in hypertensive patients exhibiting a normal scintigraphic perfusion pattern 205
In-hospital and 1-year mortality associated with diabetes in patients with acute heart failure: results from the ESC-HFA Heart Failure Long-Term Registry 205
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 205
The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors 205
Assessment of left ventricular volume and function by integration of simplified 3D echocardiography, tissue harmonic imaging and automated extraction of endocardial borders 204
Acute Coronaric Syndroms and FVII polymorphisms: different effects in the same gene 204
From left ventricular ejection fraction to cardiac hemodynamics: role of echocardiography in evaluating patients with heart failure 204
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 204
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 203
Bradycardia and atrial fibrillation in patients with stable coronary artery disease treated with ivabradine: An analysis from the SIGNIFY study 203
Remote monitoring of implantable devices: Should we continue to ignore it? 203
Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology 203
Improved recognition of dysfunctioning myocardial segments by longitudinal strain rate versus velocity in patients with myocardial infarction 202
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 202
Prognosis after pacemaker implantation in extreme elderly 202
EL PENSAMIENTO NARRATIVO PARA CONTRARRESTAR LAS ENFERMEDADES CARDIOVASCULARES. PRIMEROS RESULTADOS DE UN CAMINO DE PREVENCIÓN SECUNDARIA 201
Endothelial dysfunction in acute and chronic coronary syndromes: evidence for a pathogenetic role of oxidative stress 201
Totale 33.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 460.045
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.224
Totale 466.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021484 0 0 0 0 0 0 0 0 0 0 0 484
2021/20227.070 323 777 577 273 413 357 359 366 296 505 753 2.071
2022/20236.078 715 190 226 668 982 900 219 634 840 60 397 247
2023/20243.481 359 433 210 120 238 490 152 206 77 160 153 883
2024/202512.621 303 307 1.107 466 1.429 1.036 462 840 2.357 1.378 1.541 1.395
2025/202641.796 3.125 1.753 4.140 4.576 4.727 2.266 3.572 2.131 9.331 4.023 1.894 258
Totale 108.151